company background image
RAC

Race Oncology ASX:RAC Stock Report

Last Price

AU$1.99

Market Cap

AU$320.8m

7D

-0.5%

1Y

-32.1%

Updated

29 Jan, 2023

Data

Company Financials

RAC Stock Overview

Race Oncology Limited operates as a precision oncology company in Australia.

RAC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Race Oncology Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Race Oncology
Historical stock prices
Current Share PriceAU$1.99
52 Week HighAU$3.14
52 Week LowAU$1.45
Beta1.78
1 Month Change-1.00%
3 Month Change-17.43%
1 Year Change-32.08%
3 Year Change729.17%
5 Year Change337.36%
Change since IPO650.94%

Recent News & Updates

Recent updates

Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 14
Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Apr 01
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

Apr 05
We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

Mar 01
What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Jan 07
How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Shareholder Returns

RACAU BiotechsAU Market
7D-0.5%-1.4%0.6%
1Y-32.1%11.8%3.5%

Return vs Industry: RAC underperformed the Australian Biotechs industry which returned 11.8% over the past year.

Return vs Market: RAC underperformed the Australian Market which returned 3.5% over the past year.

Price Volatility

Is RAC's price volatile compared to industry and market?
RAC volatility
RAC Average Weekly Movement5.3%
Biotechs Industry Average Movement9.1%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.5%

Stable Share Price: RAC is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: RAC's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011n/aPhil Lynchhttps://www.raceoncology.com

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations.

Race Oncology Limited Fundamentals Summary

How do Race Oncology's earnings and revenue compare to its market cap?
RAC fundamental statistics
Market CapAU$320.77m
Earnings (TTM)-AU$11.20m
Revenue (TTM)AU$761.72k

421.1x

P/S Ratio

-28.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RAC income statement (TTM)
RevenueAU$761.72k
Cost of RevenueAU$990.26k
Gross Profit-AU$228.54k
Other ExpensesAU$10.97m
Earnings-AU$11.20m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.069
Gross Margin-30.00%
Net Profit Margin-1,470.61%
Debt/Equity Ratio0%

How did RAC perform over the long term?

See historical performance and comparison